The safety and acceptability of twice-daily deferiprone for transfusional iron overload: A multicentre, open-label, phase 2 study.
| Title | The safety and acceptability of twice-daily deferiprone for transfusional iron overload: A multicentre, open-label, phase 2 study. |
| Publication Type | Journal Article |
| Year of Publication | 2022 |
| Authors | Badawy SM, Kattamis A, Ezzat H, Deschamps B, Sicard E, Fradette C, Zhao F, Tricta F, Tsang YChung, Sheth S, Piga A |
| Journal | Br J Haematol |
| Volume | 197 |
| Issue | 1 |
| Pagination | e12-e15 |
| Date Published | 2022 04 |
| ISSN | 1365-2141 |
| Keywords | Deferiprone, Humans, Iron Chelating Agents, Iron Overload |
| DOI | 10.1111/bjh.17999 |
| Alternate Journal | Br J Haematol |
| PubMed ID | 34931307 |
| PubMed Central ID | PMC9303221 |
